Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Cas proteins: dodgy scaffolding in breast cancer
Giusy Tornillo1, Paola Defilippi, Sara Cabodi
1Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino 10126, Italy; European Cancer Stem Cell Research Institute and Cardiff School of Biosciences, Cardiff University, Cardiff CF24 4HQ, UK.
Abstract:
The members of the Cas protein family (p130Cas/BCAR1, Nedd9/HEF1, EFS and CASS4) are scaffold proteins required for the assembly of signal transduction complexes in response to several stimuli, such as growth factors, hormones and extracellular matrix components. Given their ability to integrate and coordinate multiple signalling events, Cas proteins have emerged as crucial players in the control of mammary cell proliferation, survival and differentiation. More importantly, it has been found that alterations of their expression levels result in aberrant signalling cascades, which promote initiation and progression of breast cancer. Based on the increasing data from in vitro, mouse model and clinical studies, in this review we will focus on two Cas proteins, p130Cas/BCAR1 and Nedd9, and their coupled signalling pathways, to examine their role in mammary cell transformation and in the acquirement of invasiveness and drug resistance of breast cancer cells.
Insights
Cas proteins like p130Cas/BCAR1 and Nedd9 are crucial for mammary cell functions. Aberrant signaling involving these proteins drives breast cancer initiation, progression, invasiveness, and drug resistance.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- Cas proteins (p130Cas/BCAR1, Nedd9, EFS, CASS4) are essential scaffold proteins.
- They integrate signals from growth factors, hormones, and extracellular matrix.
- Cas proteins regulate mammary cell proliferation, survival, and differentiation.
Purpose of the Study:
- To review the role of p130Cas/BCAR1 and Nedd9 in breast cancer.
- To examine their involvement in mammary cell transformation.
- To investigate their contribution to invasiveness and drug resistance.
Main Methods:
- Review of in vitro studies
- Analysis of mouse models
- Examination of clinical data
Main Results:
- Altered Cas protein expression leads to aberrant signaling cascades.
- These alterations promote breast cancer initiation and progression.
- p130Cas/BCAR1 and Nedd9 pathways are key to mammary cell transformation.
Conclusions:
- Cas proteins are critical regulators of mammary cell fate.
- Dysregulation of p130Cas/BCAR1 and Nedd9 signaling drives breast cancer.
- Targeting these pathways may offer therapeutic strategies for breast cancer.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

